Table of Contents Author Guidelines Submit a Manuscript
Table of Contents Alerts

To receive news and publication updates for BioMed Research International, enter your email address in the box below.

BioMed Research International
Volume 2014, Article ID 316272, 23 pages
http://dx.doi.org/10.1155/2014/316272
Review Article

Multiparametric MRI for Recurrent Prostate Cancer Post Radical Prostatectomy and Postradiation Therapy

Flavio Barchetti and Valeria Panebianco

Department of Radiological Sciences, Oncology and Pathology, Sapienza University of Rome, 00186 Rome, Italy

Received 17 January 2014; Accepted 25 April 2014; Published 25 May 2014

Academic Editor: Tarık Esen

Copyright © 2014 Flavio Barchetti and Valeria Panebianco. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. R. Cooperberg, J. M. Broering, and P. R. Carroll, “Time trends and local variation in primary treatment of localized prostate cancer,” Journal of Clinical Oncology, vol. 28, no. 7, pp. 1117–1123, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. G. D. Grossfeld, D. M. Stier, S. C. Flanders et al., “Use of second treatment following definitive local therapy for prostate cancer: data from the capsure database,” Journal of Urology, vol. 160, no. 4, pp. 1398–1404, 1998. View at Publisher · View at Google Scholar · View at Scopus
  3. J. M. Silverman and T. L. Krebs, “MR imaging evaluation with a transrectal surface coil of local recurrence of prostatic cancer in men who have undergone radical prostatectomy,” The American Journal of Roentgenology, vol. 168, no. 2, pp. 379–385, 1997. View at Publisher · View at Google Scholar
  4. T. Sella, L. H. Schwartz, P. W. Swindle et al., “Suspected local recurrence after radical prostatectomy: endorectal coil MR imaging,” Radiology, vol. 231, no. 2, pp. 379–385, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Cirillo, M. Petracchini, L. Scotti et al., “Endorectal magnetic resonance imaging at 1.5 Tesla to assess local recurrence following radical prostatectomy using T2-weighted and contrast-enhanced imaging,” European Radiology, vol. 19, no. 3, pp. 761–769, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Casciani, E. Polettini, E. Carmenini et al., “Endorectal and dynamic contrast-enhanced MRI for detection of local recurrence after radical prostatectomy,” The American Journal of Roentgenology, vol. 190, no. 5, pp. 1187–1192, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Sciarra, V. Panebianco, S. Salciccia et al., “Role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer,” European Urology, vol. 54, no. 3, pp. 589–600, 2008. View at Publisher · View at Google Scholar
  8. V. Panebianco, A. Sciarra, D. Lisi et al., “Prostate cancer: 1HMRS-DCEMR at 3T versus [(18)F]choline PET/CT in the detection of local prostate cancer recurrence in men with biochemical progression after radical retropubic prostatectomy (RRP),” European Journal of Radiology, vol. 81, no. 4, pp. 700–708, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. L. M. Wu, J. R. Xu, H. Y. Gu et al., “Role of magnetic resonance imaging in the detection of local prostate cancer recurrence after external beam radiotherapy and radical prostatectomy,” Clinical Oncology, vol. 25, no. 4, pp. 252–264, 2013. View at Publisher · View at Google Scholar
  10. V. Panebianco, F. Barchetti, A. Sciarra et al., “Prostate cancer recurrence after radical prostatectomy: the role of 3-T diffusion imaging in multi-parametric magnetic resonance imaging,” European Radiology, vol. 23, no. 6, pp. 1745–1752, 2013. View at Publisher · View at Google Scholar
  11. C. Roy, F. Foudi, J. Charton et al., “Comparative sensitivities of functional MRI sequences in detection of local recurrence of prostate carcinoma after radical prostatectomy or external-beam radiotherapy,” The American Journal of Roentgenology, vol. 200, no. 4, pp. W361–W368, 2013. View at Publisher · View at Google Scholar
  12. E. Sala, S. C. Eberhardt, O. Akin et al., “Endorectal MR imaging before salvage prostatectomy: tumor localization and staging,” Radiology, vol. 238, no. 1, pp. 176–183, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. A. C. Westphalen, J. Kurhanewicz, R. M. G. Cunha et al., “T2-weighted endorectal magnetic resonance imaging of prostate cancer after external beam radiation therapy,” International Brazilian Journal of Urology, vol. 35, no. 2, pp. 171–180, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. O. Rouvière, O. Valette, S. Grivolat et al., “Recurrent prostate cancer after external beam radiotherapy: value of contrast-enhanced dynamic MRI in localizing intraprostatic tumor—correlation with biopsy findings,” Urology, vol. 63, no. 5, pp. 922–927, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. M. A. Haider, P. Chung, J. Sweet et al., “Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy,” International Journal of Radiation Oncology, Biology, Physics, vol. 70, no. 2, pp. 425–430, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Kara, D. Akata, F. Akyol, M. Karçaaltincaba, and M. Özmen, “The value of dynamic contrast-enhanced MRI in the detection of recurrent prostate cancer after external beam radiotherapy: correlation with transrectal ultrasound and pathological findings,” Diagnostic and Interventional Radiology, vol. 17, no. 1, pp. 38–43, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Menard, I. C. P. Smith, R. L. Somorjai et al., “Magnetic resonance spectroscopy of the malignant prostate gland after radiotherapy: a histopathologic study of diagnostic validity,” International Journal of Radiation Oncology, Biology, Physics, vol. 50, no. 2, pp. 317–323, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. F. V. Coakley, S. T. Hui, A. Qayyum et al., “Endorectal MR imaging and MR spectroscopic imaging for locally recurrent prostate cancer after external beam radiation therapy: preliminary experience,” Radiology, vol. 233, no. 2, pp. 441–448, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. D. Pucar, A. Shukla-Dave, H. Hricak et al., “Prostate cancer: correlation of MR imaging and MR spectroscopy with pathologic findings after radiation therapy—initial experience,” Radiology, vol. 236, no. 2, pp. 545–553, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. A. C. Westphalen, F. V. Coakley, M. Roach III, C. E. McCulloch, and J. Kurhanewicz, “Locally recurrent prostate cancer after external beam radiation therapy: diagnostic performance of 1.5-T endorectal MR imaging and MR spectroscopic imaging for detection,” Radiology, vol. 256, no. 2, pp. 485–492, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Tamada, T. Sone, Y. Jo et al., “Locally recurrent prostate cancer after high-dose-rate brachytherapy: the value of diffusion-weighted imaging, dynamic contrast-enhanced MRI and T2-weighted imaging in localizing tumors,” American Journal of Roentgenology, vol. 197, no. 2, pp. 408–414, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. C. K. Kim, B. K. Park, and H. M. Lee, “Prediction of locally recurrent prostate cancer after radiation therapy: incremental value of 3T diffusion-weighted MRI,” Journal of Magnetic Resonance Imaging, vol. 29, no. 2, pp. 391–397, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. V. A. Morgan, S. F. Riches, S. Giles, D. Dearnaley, and N. M. DeSouza, “Diffusion-weighted MRI for locally recurrent prostate cancer after external beam radiotherapy,” The American Journal of Roentgenology, vol. 198, no. 3, pp. 596–602, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Hara, Y. Inoue, T. Satoh et al., “Diffusion-weighted imaging of local recurrent prostate cancer after radiation therapy: comparison with 22-core three-dimensional prostate mapping biopsy,” Magnetic Resonance Imaging, vol. 30, no. 8, pp. 1091–1098, 2012. View at Publisher · View at Google Scholar
  25. N. Arumainayagam, S. Kumaar, H. U. Ahmed et al., “Accuracy of multiparametric magnetic resonance imaging in detecting recurrent prostate cancer after radiotherapy,” The British Journal of Urology International, vol. 106, no. 7, pp. 991–997, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. A. C. Westphalen, G. D. Reed, P. P. Vinh, C. Sotto, D. B. Vigneron, and J. Kurhanewicz, “Multiparametric 3T endorectal mri after external beam radiation therapy for prostate cancer,” Journal of Magnetic Resonance Imaging, vol. 36, no. 2, pp. 430–437, 2012. View at Publisher · View at Google Scholar
  27. C. K. Kim, B. K. Park, W. Park, and S. S. Kim, “Prostate MR imaging at 3T using a phasedarrayed coil in predicting locally recurrent prostate cancer after radiation therapy: preliminary experience,” Abdominal Imaging, vol. 35, no. 2, pp. 246–252, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. O. Akin, D. H. Gultekin, H. A. Vargas et al., “Incremental value of diffusion weighted and dynamic contrast enhanced MRI in the detection of locally recurrent prostate cancer after radiation treatment: preliminary results,” European Radiology, vol. 21, no. 9, pp. 1970–1978, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. O. F. Donati, S. I. Jung, H. A. Vargas et al., “Multiparametric prostate MR imaging with T2-weighted, diffusion-weighted, and dynamic contrast-enhanced sequences: are all pulse sequences necessary to detect locally recurrent prostate cancer after radiation therapy?” Radiology, vol. 268, no. 2, pp. 440–450, 2013. View at Publisher · View at Google Scholar
  30. A. M. Murphy, D. S. Berkman, M. Desai, M. C. Benson, J. M. McKiernan, and K. K. Badani, “The number of negative pelvic lymph nodes removed does not affect the risk of biochemical failure after radical prostatectomy,” The British Journal of Urology International, vol. 105, no. 2, pp. 176–179, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. E. Brunocilla, C. Pultrone, R. Pernetti, R. Schiavina, and G. Martorana, “Preservation of the smooth muscular internal (vesical) sphincter and of the proximal urethra during retropubic radical prostatectomy: description of the technique,” International Journal of Urology, vol. 19, no. 8, pp. 783–785, 2012. View at Publisher · View at Google Scholar
  32. A. V. D'Amico, J. Crook, C. J. Beard, T. L. DeWeese, M. Hurwitz, and I. Kaplan, “Radiation therapy for prostate cancer,” in Campbell's Urology, P. C. Walsh and A. B. Retik, Eds., pp. 3147–3170, WB Saunders, Philadelphia, Pa, USA, 8th edition, 2002. View at Google Scholar
  33. A. Y. Olsson, A. Bjartell, H. Lilja, and Å. Lundwall, “Expression of Prostate-specific antigen (PSA) and human glandular kallikrein 2 (hK2) in ileum and other extraprostatic tissues,” International Journal of Cancer, vol. 113, no. 2, pp. 290–297, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. European Association of Urology, Guidelines on Prostate Cancer, EAU, Arnhem, The Netherlands, 2012.
  35. R. Schiavina, F. Ceci, M. Borghesi et al., “The dilemma of localizing disease relapse after radical treatment for prostate cancer: which is the value of the actual imaging techniques?” Current Radiopharmaceuticals, vol. 6, no. 2, pp. 92–95, 2013. View at Publisher · View at Google Scholar
  36. A. Heidenreich, G. Aus, M. Bolla et al., “EAU guidelines on prostate cancer,” European Urology, vol. 53, no. 1, pp. 68–80, 2008. View at Google Scholar
  37. D. A. Loblaw, D. S. Mendelson, J. A. Talcott et al., “American society of clinical oncology recommendations for the initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer,” Journal of Clinical Oncology, vol. 22, no. 14, pp. 2927–2941, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Caloglu and J. Ciezki, “Prostate-specific antigen bounce after prostate brachytherapy: review of a confusing phenomenon,” Urology, vol. 74, no. 6, pp. 1183–1190, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. S. L. Hancock, R. S. Cox, and M. A. Bagshaw, “Prostate specific antigen after radiotherapy for prostate cancer: a reevaluation of long-term biochemical control and the kinetics of recurrence in patients treated at Stanford University,” Journal of Urology, vol. 154, no. 4, pp. 1412–1417, 1995. View at Publisher · View at Google Scholar · View at Scopus
  40. F. A. Vicini, C. Vargas, A. Abner, L. Kestin, E. Horwitz, and A. Martinez, “Limitations in the use of serum prostate specific antigen levels to monitor patients after treatment for prostate cancer,” Journal of Urology, vol. 173, no. 5, pp. 1456–1462, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. S. E. Cotter, M. H. Chen, J. W. Moul et al., “Salvage radiation in men after prostate-specific antigen failure and the risk of death,” Cancer, vol. 117, no. 17, pp. 3925–3932, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. J. O. Barentsz, J. Richenberg, R. Clements et al., “ESUR prostate MR guidelines 2012,” European Radiology, vol. 22, no. 4, pp. 746–757, 2012. View at Publisher · View at Google Scholar
  43. I. Ocak, M. Bernardo, G. Metzger et al., “Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters,” The American Journal of Roentgenology, vol. 189, no. 4, p. 849, 2007. View at Google Scholar · View at Scopus
  44. M. Haghighi, S. Shah, S. S. Taneja, and A. B. Rosenkrantz, “Prostate cancer: diffusion-weighted imaging versus dynamic-contrast enhanced imaging for tumor localization—a meta-analysis,” Journal of Computer Assisted Tomography, vol. 37, no. 6, pp. 980–988, 2013. View at Publisher · View at Google Scholar
  45. V. Panebianco, F. Barchetti, A. Sciarra et al., “In vivo 3D neuroanatomical evaluation of periprostatic nerve plexus with 3T-MR diffusion tensor imaging,” European Journal of Radiology, vol. 82, no. 10, pp. 1677–1682, 2013. View at Publisher · View at Google Scholar
  46. K. Saito, T. Kaminaga, S. Muto et al., “Clinical efficacy of proton magnetic resonance spectroscopy (1H-MRS) in the diagnosis of localized prostate cancer,” Anticancer Research, vol. 28, no. 3, pp. 1899–1904, 2008. View at Google Scholar · View at Scopus
  47. J. Kurhanewicz, R. Dahiya, J. M. MacDonald, L. Chang, T. L. James, and P. Narayan, “Citrate alterations in primary and metastatic human prostatic adenocarcinomas: 1H magnetic resonance spectroscopy and biochemical study,” Magnetic Resonance in Medicine, vol. 29, no. 2, pp. 149–157, 1993. View at Google Scholar · View at Scopus
  48. A. P. S. Kirkham, M. Emberton, and C. Allen, “How good is MRI at detecting and characterising cancer within the prostate?” European Urology, vol. 50, no. 6, pp. 1163–1175, 2006. View at Publisher · View at Google Scholar · View at Scopus
  49. C. R. King and M. T. Spiotto, “Improved outcomes with higher doses for salvage radiotherapy after prostatectomy,” International Journal of Radiation Oncology, Biology, Physics, vol. 71, no. 1, pp. 23–27, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. A. K. Leventis, S. F. Shariat, M. W. Kattan, E. B. Butler, T. M. Wheeler, and K. M. Slawin, “Prediction of response to salvage radiation therapy in patients with prostrate cancer recurrence after radical prostatectomy,” Journal of Clinical Oncology, vol. 19, no. 4, pp. 1030–1039, 2001. View at Google Scholar · View at Scopus
  51. C. Deliveliotis, T. Manousakas, M. Chrisofos, A. Skolarikos, A. Delis, and C. Dimopoulos, “Diagnostic efficacy of transrectal ultrasound-guided biopsy of the prostatic fossa in patients with rising PSA following radical prostatectomy,” World Journal of Urology, vol. 25, no. 3, pp. 309–313, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. V. Scattoni, M. Roscigno, M. Raber et al., “Multiple vesico-urethral biopsies following radical prostatectomy: the predictive roles of TRUS, DRE, PSA and the pathological stage,” European Urology, vol. 44, no. 4, pp. 407–414, 2003. View at Publisher · View at Google Scholar · View at Scopus
  53. A. K. Leventis, S. F. Shariat, and K. M. Slawin, “Local recurrence after radical prostatectomy: correlation of US features with prostatic fossa biopsy findings,” Radiology, vol. 219, no. 2, pp. 432–439, 2001. View at Google Scholar · View at Scopus
  54. V. Scattoni, M. Roscigno, M. Raber, P. Consonni, L. Da Pozzo, and P. Rigatti, “Biopsy of the vesico-urethral anastomosis after radical prostatectomy: when and how,” European Urology Supplements, vol. 1, no. 6, pp. 89–95, 2002. View at Publisher · View at Google Scholar · View at Scopus
  55. V. Scattoni, F. Montorsi, M. Picchio et al., “Diagnosis of local recurrence after radical prostatectomy,” The British Journal of Urology International, vol. 93, no. 5, pp. 680–688, 2004. View at Publisher · View at Google Scholar · View at Scopus
  56. S. Tamsel, R. Killi, E. Apaydin, M. Hekimgil, and G. Demirpolat, “The potential value of power Doppler ultrasound imaging compared with grey-scale ultrasound findings in the diagnosis of local recurrence after radical prostatectomy,” Clinical Radiology, vol. 61, no. 4, pp. 325–330, 2006. View at Publisher · View at Google Scholar · View at Scopus
  57. F. M. Drudi, F. Giovagnorio, A. Carbone et al., “Transrectal colour Doppler contrast sonography in the diagnosis of local recurrence after radical prostatectomy—comparison with MRI,” Ultraschall in der Medizin, vol. 27, no. 2, pp. 146–151, 2006. View at Publisher · View at Google Scholar · View at Scopus
  58. C. J. Kane, C. L. Amling, P. A. S. Johnstone et al., “Limited value of bone scintigraphy and computed tomography in assessing biochemical failure after radical prostatectomy,” Urology, vol. 61, no. 3, pp. 607–611, 2003. View at Publisher · View at Google Scholar · View at Scopus
  59. S. Kramer, J. Gorich, H. W. Gottfried et al., “Sensitivity of computed tomography in detecting local recurrence of prostatic carcinoma following radical prostatectomy,” The British Journal of Radiology, vol. 70, pp. 995–999, 1997. View at Google Scholar
  60. G. Giovacchini, M. Picchio, E. Coradeschi et al., “Predictive factors of [11C]choline PET/CT in patients with biochemical failure after radical prostatectomy,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 37, no. 2, pp. 301–309, 2010. View at Publisher · View at Google Scholar · View at Scopus
  61. S. N. Reske, N. M. Blumstein, and G. Glatting, “[11C]choline PET/CT imaging in occult local relapse of prostate cancer after radical prostatectomy,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 35, no. 1, pp. 9–17, 2008. View at Publisher · View at Google Scholar · View at Scopus
  62. H. A. Vargas, C. Wassberg, O. Akin, and H. Hricak, “MR imaging of treated prostate cancer,” Radiology, vol. 262, no. 1, pp. 26–42, 2012. View at Publisher · View at Google Scholar · View at Scopus
  63. D. P. Nguyen, G. Giannarini, R. Seiler et al., “Local recurrence after retropubic radical prostatectomy for prostate cancer does not exclusively occur at the anastomotic site,” The British Journal of Urology International, vol. 112, no. 4, pp. 243–249, 2013. View at Google Scholar
  64. S. D. Allen, A. Thompson, and S. A. Sohaib, “The normal post-surgical anatomy of the male pelvis following radical prostatectomy as assessed by magnetic resonance imaging,” European Radiology, vol. 18, no. 6, pp. 1281–1291, 2008. View at Publisher · View at Google Scholar · View at Scopus
  65. J. Sefrova, K. Odrazka, P. Paluska et al., “Magnetic resonance imaging in postprostatectomy radiotherapy planning,” International Journal of Radiation Oncology, Biology, Physics, vol. 82, no. 2, pp. 911–918, 2012. View at Publisher · View at Google Scholar · View at Scopus
  66. Walters Kluwer, Perez and Brady's Principles and Practice of Radiation Oncology, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 5th edition, 2007.
  67. V. Panebianco, F. Giove, F. Barchetti, F. Podo, and R. Passariello, “High-field PET/MRI and MRS: potential clinical and research applications,” Clinical and Translational Imaging, vol. 1, no. 1, pp. 17–29, 2013. View at Publisher · View at Google Scholar
  68. D. Thorwarth, S. Leibfarth, and D. Mönnich, “Potential role of PET/MRI in radiotherapy treatment planning,” Clinical and Translational Imaging, vol. 1, no. 1, pp. 45–51, 2013. View at Publisher · View at Google Scholar
  69. D. M. Somford, J. J. Fütterer, T. Hambrock, and J. O. Barentsz, “Diffusion and Perfusion MR Imaging of the Prostate,” Magnetic Resonance Imaging Clinics of North America, vol. 16, no. 4, pp. 685–695, 2008. View at Publisher · View at Google Scholar · View at Scopus
  70. G. Giannarini, D. P. Nguyen, G. N. Thalmann, and H. C. Thoeny, “Diffusion-weighted magnetic resonance imaging detects local recurrence after radical prostatectomy: initial experience,” European Urology, vol. 61, no. 3, pp. 616–620, 2012. View at Publisher · View at Google Scholar · View at Scopus
  71. F. J. Bianco Jr., P. T. Scardino, A. J. Stephenson, C. J. DiBlasio, P. A. Fearn, and J. A. Eastham, “Long-term oncologic results of salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy,” International Journal of Radiation Oncology, Biology, Physics, vol. 62, no. 2, pp. 448–453, 2005. View at Publisher · View at Google Scholar · View at Scopus
  72. G. L. Gravina, V. Tombolini, M. Di Staso et al., “Advances in imaging and in non-surgical salvage treatments after radiorecurrence in prostate cancer: what does the oncologist, radiotherapist and radiologist need to know?” European Radiology, vol. 22, no. 12, pp. 2848–2858, 2012. View at Publisher · View at Google Scholar
  73. M. R. Moman, C. A. T. van den Berg, A. E. Boeken Kruger et al., “Focal salvage guided by T2-weighted and dynamic contrast-enhanced magnetic resonance imaging for prostate cancer recurrences,” International Journal of Radiation Oncology, Biology, Physics, vol. 76, no. 3, pp. 741–746, 2010. View at Publisher · View at Google Scholar · View at Scopus
  74. J. Crook, S. Robertson, G. Collin, V. Zaleski, and B. Esche, “Clinical relevance of trans-rectal ultrasound, biopsy, and serum prostate-specific antigen following external beam radiotherapy for carcinoma of the prostate,” International Journal of Radiation Oncology, Biology, Physics, vol. 27, no. 1, pp. 31–37, 1993. View at Google Scholar · View at Scopus
  75. D. M. Nudell, A. E. Wefer, H. Hricak, and P. R. Carroll, “Imaging for recurrent prostate cancer,” Radiologic Clinics of North America, vol. 38, no. 1, pp. 213–229, 2000. View at Google Scholar · View at Scopus
  76. J. Crook, S. Malone, G. Perry, Y. Bahadur, S. Robertson, and M. Abdolell, “Postradiotherapy prostate biopsies: what do they really mean? Results for 498 patients,” International Journal of Radiation Oncology, Biology, Physics, vol. 48, no. 2, pp. 355–367, 2000. View at Publisher · View at Google Scholar · View at Scopus
  77. F. Ceci, P. Castellucci, T. Graziani et al., “11C-Choline PET/CT detects the site of relapse in the majority of prostate cancer patients showing biochemical recurrence after EBRT,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 41, no. 5, pp. 878–886, 2014. View at Publisher · View at Google Scholar
  78. F. V. Coakley, H. Hricak, A. E. Wefer, J. L. Speight, J. Kurhanewicz, and M. Roach, “Brachytherapy for prostate cancer: endorectal MR imaging of local treatment-related changes,” Radiology, vol. 219, no. 3, pp. 817–821, 2001. View at Google Scholar · View at Scopus
  79. K. Sugimura, B. M. Carrington, J. M. Quivey, and H. Hricak, “Postirradiation changes in the pelvis: assessment with MR imaging,” Radiology, vol. 175, no. 3, pp. 805–813, 1990. View at Google Scholar · View at Scopus
  80. D. Yakar, T. Hambrock, H. Huisman et al., “Feasibility of 3T dynamic contrast-enhanced magnetic resonance-guided biopsy in localizing local recurrence of prostate cancer after external beam radiation therapy,” Investigative Radiology, vol. 45, no. 3, pp. 121–125, 2010. View at Publisher · View at Google Scholar · View at Scopus
  81. F. G. Claus, H. Hricak, and R. R. Hattery, “Pretreatment evaluation of prostate cancer: role of MR imaging and 1H MR spectroscopy,” Radiographics, vol. 24, supplement 1, pp. S167–S180, 2004. View at Google Scholar · View at Scopus
  82. M. Mullerad, H. Hricak, L. Wang, H. Chen, M. W. Kattan, and P. T. Scardino, “Prostate cancer: detection of extracapsular extension by genitourinary and general body radiologists at MR imaging,” Radiology, vol. 232, no. 1, pp. 140–146, 2004. View at Publisher · View at Google Scholar · View at Scopus
  83. J. Scheidler, H. Hricak, D. B. Vigneron et al., “Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging—clinicopathologic study,” Radiology, vol. 213, no. 2, pp. 473–480, 1999. View at Google Scholar · View at Scopus
  84. A. E. Wefer, H. Hricak, D. B. Vigneron et al., “Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology,” Journal of Urology, vol. 164, no. 2, pp. 400–404, 2000. View at Google Scholar · View at Scopus
  85. O. Rouvière, T. Vitry, and D. Lyonnet, “Imaging of prostate cancer local recurrences: why and how?” European Radiology, vol. 20, no. 5, pp. 1254–1266, 2010. View at Publisher · View at Google Scholar · View at Scopus
  86. T. Franiel, L. Lüdemann, M. Taupitz, D. Böhmer, and D. Beyersdorff, “MRI before and after external beam intensity-modulated radiotherapy of patients with prostate cancer: the feasibility of monitoring of radiation-induced tissue changes using a dynamic contrast-enhanced inversion-prepared dual-contrast gradient echo sequence,” Radiotherapy and Oncology, vol. 93, no. 2, pp. 241–245, 2009. View at Publisher · View at Google Scholar · View at Scopus
  87. R. N. Low, D. B. Fuller, and N. Muradyan, “Dynamic gadolinium-enhanced perfusion MRI of prostate cancer: assessment of response to hypofractionated robotic stereotactic body radiation therapy,” The American Journal of Roentgenology, vol. 197, no. 4, pp. 907–915, 2011. View at Publisher · View at Google Scholar · View at Scopus
  88. J. J. Fütterer, T. W. J. Scheenen, H. J. Huisman et al., “Initial experience of 3 tesla endorectal coil magnetic resonance imaging and 1H-spectroscopic imaging of the prostate,” Investigative Radiology, vol. 39, no. 11, pp. 671–680, 2004. View at Publisher · View at Google Scholar · View at Scopus
  89. A. L. Valentini, B. Gui, G. R. D'Agostino et al., “Locally advanced prostate cancer: three-dimensional magnetic resonance spectroscopy to monitor prostate response to therapy,” International Journal of Radiation Oncology, Biology, Physics, vol. 84, no. 3, pp. 719–724, 2012. View at Publisher · View at Google Scholar
  90. V. Panebianco, F. Barchetti, D. Musio et al., “Metabolic atrophy and 3T 1H-MR spectroscopy correlation after radiation therapy for prostate cancer,” The British Journal of Urology International, 2014. View at Publisher · View at Google Scholar
  91. U. G. Mueller-Lisse, D. B. Vigneron, H. Hricak et al., “Localized prostate cancer: effect of hormone deprivation therapy measured by using combined three-dimensional 1H MR spectroscopy and MR imaging: clinicopathologic case-controlled study,” Radiology, vol. 221, no. 2, pp. 380–390, 2001. View at Google Scholar · View at Scopus
  92. D. Pucar, H. Hricak, A. Shukla-Dave et al., “Clinically significant prostate cancer local recurrence after radiation therapy occurs at the site of primary tumor: magnetic resonance imaging and step-section pathology evidence,” International Journal of Radiation Oncology, Biology, Physics, vol. 69, no. 1, pp. 62–69, 2007. View at Publisher · View at Google Scholar · View at Scopus
  93. D. A. Hamstra, A. Rehemtulla, and B. D. Ross, “Diffusion magnetic resonance imaging: a biomarker for treatment response in oncology,” Journal of Clinical Oncology, vol. 25, no. 26, pp. 4104–4109, 2007. View at Publisher · View at Google Scholar · View at Scopus
  94. I. Song, C. K. Kim, B. K. Park, and W. Park, “Assessment of response to radiotherapy for prostate cancer: value of diffusion-weighted MRI at 3 T,” The American Journal of Roentgenology, vol. 194, no. 6, pp. W477–W482, 2010. View at Publisher · View at Google Scholar · View at Scopus
  95. Y. Takayama, R. Kishimoto, S. Hanaoka et al., “ADC value and diffusion tensor imaging of prostate cancer: changes in carbon-ion radiotherapy,” Journal of Magnetic Resonance Imaging, vol. 27, no. 6, pp. 1331–1335, 2008. View at Publisher · View at Google Scholar · View at Scopus
  96. I. Song, C. K. Kim, B. K. Park, and W. Park, “Assessment of response to radiotherapy for prostate cancer: value of diffusion-weighted MRI at 3 T,” The American Journal of Roentgenology, vol. 194, no. 6, pp. W477–W482, 2010, Erratum in The American Journal of Roentgenology, vol. 195, no. 2, p. 534, 2010. View at Publisher · View at Google Scholar
  97. P. A. Hein, C. Kremser, W. Judmaier et al., “Diffusion-weighted magnetic resonance imaging for monitoring diffusion changes in rectal carcinoma during combined, preoperative chemoradiation: preliminary results of a prospective study,” European Journal of Radiology, vol. 45, no. 3, pp. 214–222, 2003. View at Publisher · View at Google Scholar · View at Scopus
  98. A. B. Rosenkrantz, M. Kopec, X. Kong et al., “Prostate cancer versus post-biopsy hemorrhage: diagnosis with T2- and diffusion-weighted imaging,” Journal of Magnetic Resonance Imaging, vol. 31, no. 6, pp. 1387–1394, 2010. View at Publisher · View at Google Scholar · View at Scopus
  99. K. Katahira, T. Takahara, T. C. Kwee et al., “Ultra-high-b-value diffusion-weighted MR imaging for the detection of prostate cancer: evaluation in 201 cases with histopathological correlation,” European Radiology, vol. 21, no. 1, pp. 188–196, 2011. View at Publisher · View at Google Scholar · View at Scopus
  100. K. Kitajima, Y. Kaji, K. Kuroda, and K. Sugimura, “High b-value diffusion-weighted imaging in normal and malignant peripheral zone tissue of the prostate: effect of signal-to-noise ratio,” Magnetic Resonance in Medical Sciences, vol. 7, no. 2, pp. 93–99, 2008. View at Publisher · View at Google Scholar · View at Scopus
  101. T. Kobus, P. C. Vos, T. Hambrock et al., “Prostate cancer aggressiveness: in vivo assessment of MR spectroscopy and diffusion-weighted imaging at 3 T,” Radiology, vol. 265, no. 2, pp. 457–467, 2012. View at Publisher · View at Google Scholar
  102. A. Oto, C. Yang, A. Kayhan et al., “Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with gleason score and tumor angiogenesis,” The American Journal of Roentgenology, vol. 197, no. 6, pp. 1382–1390, 2011. View at Publisher · View at Google Scholar · View at Scopus
  103. H. A. Vargas, O. Akin, T. Franiel et al., “Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness,” Radiology, vol. 259, no. 3, pp. 775–784, 2011. View at Publisher · View at Google Scholar · View at Scopus
  104. M. J. Beresford, D. Gillatt, R. J. Benson, and T. Ajithkumar, “A systematic review of the role of imaging before salvage radiotherapy for post-prostatectomy biochemical recurrence,” Clinical Oncology, vol. 22, no. 1, pp. 46–55, 2010. View at Publisher · View at Google Scholar · View at Scopus